Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis.


Clinical Trial Description

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis in two years. Dyslipidemia patients with intracranial arterial stenosis will be enrolled under informed consent in this study. Rosuvastatin (5mg) will be orally administered once daily. Dose of rosuvastatin will be adjusted to control serum LDL-c level under 1.8mmol/L. Primary outcome is the progression of intracranial stenosis on magnetic resonance angiography (MRA) after two years. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02341794
Study type Interventional
Source Tokyo Medical University
Contact Hitoshi Aizawa, MD, PhD
Phone +813-3342-6111
Email haizawa@tokyo-med.ac.jp
Status Recruiting
Phase N/A
Start date January 2015
Completion date July 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05063630 - Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke N/A
Completed NCT00703794 - Researching AXIUM Coiling Experience and Recanalization (RACER)
Completed NCT03916133 - Analysis of Selective Cerebrovascular Distribution With FDCT in the Angiosuite N/A
Completed NCT05217459 - The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease N/A